NeuroProtect, a Candidate Formula From Traditional Chinese Medicine, Attenuates Amyloid-β and Restores Synaptic Structures in APP/PS1 Transgenic Mice

• Päätekijät: Yan Tan (Tekijä), Xu Wang (Tekijä), Jiani Zhang (Tekijä), Huawei Zhang (Tekijä), Haiyan Li (Tekijä), Tiantian Peng (Tekijä), Weihang Chen (Tekijä), Peng Wei (Tekijä), Zhaoheng Liu (Tekijä), Fang He (Tekijä), Jiao Li (Tekijä), Haimin Ding (Tekijä), Na Li (Tekijä), Zhaoyang Wang (Tekijä), Zhenqiang Zhang (Tekijä), Qian Hua (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2022-05-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Alzheimer's disease (AD) is the most common cause of dementia. The emerging data suggest that cognitive decline occurred in the setting of Aβ accumulation with synaptic dysfunction, which started to happen at preclinical stages. Then, presymptomatic intervention is more critical to...